We are live on ! Find out more
CSIC

Clifford Swan Investment Counsel Portfolio holdings

AUM $2.94B
1-Year Est. Return 21.31%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+21.31%
3 Year Est. Return
+60.82%
5 Year Est. Return
+91.5%
10 Year Est. Return
+310.89%
AUM
$2.78B
AUM Growth
-$40.9M
Cap. Flow
-$33.5M
Cap. Flow %
-1.21%
Top 10 Hldgs %
32.32%
Holding
315
New
3
Increased
39
Reduced
168
Closed
10

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.23M
2
ALSN icon
Allison Transmission
ALSN
+$2.1M
3
AAPL icon
Apple
AAPL
+$2.05M
4
WFC icon
Wells Fargo
WFC
+$1.99M
5
COST icon
Costco
COST
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Industrials 14.02%
3 Healthcare 11.71%
4 Consumer Discretionary 10.99%
5 Financials 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
26
Intuit
INTU
$91.6B
$27.6M 0.99%
43,847
-602
-1% -$385K
QCOM icon
27
Qualcomm
QCOM
$171B
$27.4M 0.99%
178,400
-2,304
-1% -$377K
PG icon
28
Procter & Gamble
PG
$335B
$25.5M 0.92%
151,893
-3,501
-2% -$596K
RTX icon
29
RTX Corp
RTX
$300B
$25.4M 0.91%
219,195
-705
-0.3% -$85.2K
UNH icon
30
UnitedHealth
UNH
$364B
$25.3M 0.91%
50,019
-2,043
-4% -$1.16M
HPQ icon
31
HP
HPQ
$26.8B
$24.6M 0.89%
755,148
-12,350
-2% -$444K
JCI icon
32
Johnson Controls International
JCI
$92.6B
$24.6M 0.89%
311,799
+61
+0% +$4.89K
ABT icon
33
Abbott
ABT
$192B
$24.2M 0.87%
213,699
-4,069
-2% -$470K
BMY icon
34
Bristol-Myers Squibb
BMY
$130B
$24.2M 0.87%
427,038
-30,078
-7% -$1.68M
MCK icon
35
McKesson
MCK
$102B
$23.8M 0.86%
41,732
-1,066
-2% -$597K
CSCO icon
36
Cisco
CSCO
$488B
$23.6M 0.85%
398,229
-5,569
-1% -$318K
MCD icon
37
McDonald's
MCD
$195B
$23.5M 0.85%
81,092
-4,886
-6% -$1.46M
LH icon
38
Labcorp
LH
$26.2B
$22.5M 0.81%
97,996
+1,614
+2% +$370K
BKNG icon
39
Booking.com
BKNG
$159B
$22.2M 0.8%
111,450
-5,550
-5% -$1.07M
GLD icon
40
SPDR Gold Trust
GLD
$144B
$21.2M 0.76%
87,368
-1,099
-1% -$270K
DD icon
41
DuPont de Nemours
DD
$19.5B
$20.1M 0.72%
209,596
-6,015
-3% -$626K
A icon
42
Agilent Technologies
A
$41.9B
$19.4M 0.7%
144,480
-1,173
-0.8% -$161K
EW icon
43
Edwards Lifesciences
EW
$53.6B
$18.8M 0.68%
253,593
-832
-0.3% -$58.2K
PYPL icon
44
PayPal
PYPL
$50.6B
$18.4M 0.66%
215,459
-8,181
-4% -$688K
META icon
45
Meta Platforms (Facebook)
META
$1.47T
$18.1M 0.65%
30,972
+12
+0% +$7.04K
KMX icon
46
CarMax
KMX
$8.33B
$18M 0.65%
219,602
+6,038
+3% +$474K
SLB icon
47
SLB Ltd
SLB
$78.1B
$17.5M 0.63%
455,664
+16,274
+4% +$683K
PEP icon
48
PepsiCo
PEP
$189B
$17.4M 0.63%
114,381
+5,278
+5% +$865K
PH icon
49
Parker-Hannifin
PH
$135B
$17M 0.61%
26,696
IFF icon
50
International Flavors & Fragrances
IFF
$21.4B
$17M 0.61%
200,650
-10,022
-5% -$942K

Similar funds

Clifford Swan Investment Counsel's Q4 2024 Portfolio in Review

As of Q4 2024, Clifford Swan Investment Counsel held 315 positions worth $2.78B, down 1.4% from $2.82B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.1%. Clifford Swan Investment Counsel opened 3 new positions and exited 10, leaving the 315-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.

  • Clifford Swan Investment Counsel's largest Q4 2024 buy was Williams Companies: 4,164 shares worth $225K.
  • Clifford Swan Investment Counsel added most to Ferguson in Q4 2024, an estimated $3.51M increase.
  • Clifford Swan Investment Counsel's biggest Q4 2024 reduction was Microsoft, cutting an estimated $2.23M.
  • Clifford Swan Investment Counsel fully exited Stericycle Inc in Q4 2024, selling an estimated $661K.
  • Clifford Swan Investment Counsel's ten largest holdings make up 32% of its $2.78B portfolio in Q4 2024.
  • Clifford Swan Investment Counsel opened 3 new positions and closed 10 in Q4 2024.
  • Clifford Swan Investment Counsel's portfolio value fell 1.4% quarter-over-quarter to $2.78B.

Based on Clifford Swan Investment Counsel's 13F filing for Q4 2024, filed 5 Feb 2025.